Literature DB >> 7707413

Genetic instability and tumor cell variation: implications for immunotherapy.

R G Fenton, D L Longo.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7707413     DOI： 10.1093/jnci/87.4.241

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Tolerance and immune suppression in the tumor microenvironment.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Cell Immunol       Date:  2015-09-30       Impact factor: 4.868

Review 2.  The past, present and future of immunotherapy against tumor.

Authors:  Tao Jiang; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2015-06

Review 3.  Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies.

Authors:  Ira Surolia; James Gulley; Ravi A Madan
Journal:  Expert Opin Biol Ther       Date:  2014-09-12       Impact factor: 4.388

4.  Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.

Authors:  N P Restifo; F M Marincola; Y Kawakami; J Taubenberger; J R Yannelli; S A Rosenberg
Journal:  J Natl Cancer Inst       Date:  1996-01-17       Impact factor: 13.506

Review 5.  Emerging immunotherapies for glioblastoma.

Authors:  Rupen Desai; Carter M Suryadevara; Kristen A Batich; S Harrison Farber; Luis Sanchez-Perez; John H Sampson
Journal:  Expert Opin Emerg Drugs       Date:  2016-06       Impact factor: 4.191

6.  Identification of Pre- and Post-Treatment Markers, Clinical, and Laboratory Parameters Associated with Outcome in Renal Cancer Patients Treated with MVA-5T4.

Authors:  Rabih Said; Robert J Amato
Journal:  Front Oncol       Date:  2013-07-15       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.